Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients
- 23 August 2018
- journal article
- research article
- Published by Elsevier BV in Infectious Disease Clinics of North America
- Vol. 32 (3), 703-718
- https://doi.org/10.1016/j.idc.2018.05.002
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantationLiver Transplantation, 2013
- Risk factors and characteristics of post-transplant tuberculosis in an endemic areaAnnals of Transplantation, 2013
- QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TBTransplant Infectious Disease, 2012
- Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor-Derived Infections Consensus Conference ReportAmerican Journal of Transplantation, 2012
- Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?Nephrology Dialysis Transplantation, 2011
- Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidatesLiver Transplantation, 2011
- Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantationTransplant Infectious Disease, 2010
- Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver TransplantationAmerican Journal of Transplantation, 2007
- Screening for Tuberculosis in the Study of the Living Renal Donor in a Developing CountryTransplantation, 2006
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentThe New England Journal of Medicine, 2001